Netakimab — new IL-17а inhibitor: 12-week results of phase III clinical study BCD-085-7/PLANETA in patients with moderate-tosevere plaque psoriasis - PDF (Russian)
Copyright (c) 2019 Kubanov A.A., Bakulev A.L., Samtsov A.V., Khairutdinov V.R., Sokolovskiy E.V., Kokhan M.M., Artemyeva A.V., Chernyaeva E.V., Ivanov R.A.
![Creative Commons License](http://licensebuttons.net/l/by/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution 4.0 International License.
![](https://kazanmedjournal.ru/files/journals/10/misc/interface/16.gif)
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 60448 от 30.12.2014.